NEOANTIGEN-SPECIFIC IMMUNOTHERAPY

Clinical trials for NEOANTIGEN-SPECIFIC IMMUNOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new NEOANTIGEN-SPECIFIC IMMUNOTHERAPY trials appear

Sign up with your email to follow new studies for NEOANTIGEN-SPECIFIC IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Custom-Made vaccine trains body to fight its own cancer

Disease control Recruiting now

This study is testing a personalized cancer vaccine made from the unique mutations found in a patient's own tumor. The goal is to see if this custom vaccine, given with other immune-boosting drugs, is safe and can help control advanced or high-risk cancers. It is for adults with …

Matched conditions: NEOANTIGEN-SPECIFIC IMMUNOTHERAPY

Phase: PHASE1, PHASE2 • Sponsor: Seqker Biosciences, Inc. • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

NEOANTIGEN-SPECIFIC IMMUNOTHERAPY

Get alerted when new NEOANTIGEN-SPECIFIC IMMUNOTHERAPY trials appear

Custom-Made vaccine trains body to fight its own cancer